Enhancement effects of hepatic dynamic MR imaging at 3.0 T and 1.5 T using gadoxetic acid in a phantom study: Comparison with gadopentetate dimeglumine

Magnetic Resonance in Medicine

Volumn 66, Issue 1, 2011, Pages 213-218

  Morita, Kosuke ^a,b   Namimoto, Tomohiro ^a   Awai, Kazuo ^a   Komi, Masanori ^b   Hashida, Masahiro ^b   Tsuji, Takashi ^c   Hirai, Toshinori ^a   Yamashita, Yasuyuki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^c BAYER YAKUHIN LTD   (Japan)

Author keywords

arterial phase; dynamic MRI; gadopentetate dimeglumine; gadoxetic acid; gradient echo; phantom

Indexed keywords

MAGNETIC RESONANCE IMAGING; MAGNETISM; PHANTOMS;

ARTERIAL PHASE; DYNAMIC MAGNETIC RESONANCE IMAGING; DYNAMIC MRI; ENHANCEMENT EFFECTS; FAST LOW ANGLE SHOTS; GADOPENTETATE DIMEGLUMINE; GRADIENT ECHO; MAGNETIC FIELD STRENGTHS;

IMAGE ENHANCEMENT;

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GADOXETIC ACID;

ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; ELECTRON SPIN RESONANCE; HUMAN; IMAGING SYSTEM; LIVER BLOOD FLOW; MAGNETIC FIELD; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM;

EID: 79959553094     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22770     Document Type: Article

References (26)

1. Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, Hesse T, Berns T, Peters PE,. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 1996; 199: 177-183. (Pubitemid 26098637)
2. Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, Casalino DD, Davis PL, Francis IR, Krinsky G, Lee FT, Jr, Lu D, Paulson EK, Schwartz LH, Siegelman ES,. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005; 237: 89-98. (Pubitemid 41346150)
3. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO,. MR imaging in patients with suspected liver metastases: Value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007; 6: 43-52.
4. Žižka J, Klzo L, Ferda J, Mrklovský M, Bukač J,. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol. Eur J Radiol 2007; 62: 186-191. (Pubitemid 46560352)
5. Tschirch FTC, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D,. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 2008; 18: 1577-1586.
6. Giovanoli O, Heim M, Terracciano L, Bongartz G, Ledermann H,. MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients. AJR Am J Roentgenol 2008; 190: W290-W293. (Pubitemid 351684910)
7. Colagrande S, Paolucci ML, Messerini L, Schima W, Stadler A, Bartolotta TV, Vanzulli A, Brancatelli G,. Solitary necrotic nodules of the liver: cross-sectional imaging findings and follow-up in nine patients. AJR Am J Roentgenol 2008; 191: 1122-1128.
8. Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L,. Consensus report of the 2nd international forum for liver MRI. Eur Radiol 2009; 19 (Suppl 5): S975-S989.
9. Lee VS, Hecht EM, Taouli B, Chen Q, Prince K, Oesingmann N,. Body and cardiovascular MR imaging at 3.0 T. Radiology 2007; 244: 692-705. (Pubitemid 47292080)
10. 2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005; 54: 507-512. (Pubitemid 41233744)
11. Sasaki M, Shibata E, Kanbara Y, Ehara S,. Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 versus 3 Tesla: a phantom study. Magn Reson Med Sci 2005; 4: 145-149.
12. Ishida M, Sakuma H, Murashima S, Nishida J, Senga M, Kobayashi S, Takeda K, Kato N,. Absolute blood contrast concentration and blood signal saturation on myocardial perfusion MRI: Estimation from CT data. J Magn Reson Imaging 2009; 29: 205-210.
13. Mitchell MD, Kundel HL, Axel L, Joseph PM,. Agarose as a tissue equivalent phantom material for NMR imaging. Magn Reson Imaging 1986; 4: 263-266. (Pubitemid 16098667)
14. de Bazelaire CMJ, Duhamel GD, Rofsky NM, Alsop DC,. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: Preliminary results. Radiology 2004; 230: 652-659. (Pubitemid 38252858)
15. Nael K, Laub G, Finn JP,. Three-dimensional contrast-enhanced MR angiography of the thoraco-abdominal vessels. Magn Reson Imaging Clin N Am 2005; 13: 359-380. (Pubitemid 40780134)
16. Krishnam MS, Tomasian A, Lohan DG, Tran L, Finn JP, Ruehm SG,. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in cardiac and vascular diseases: correlation to high spatial resolution 3D contrast-enhanced MRA. Clin Radiol 2008; 63: 744-755.
17. Tsurusaki M, Semelka RC, Zapparoli M, Elias J, Jr, Altun E, Pamuklar E, Sugimura K,. Quantitative and qualitative comparison of 3.0 T and 1.5 T MR imaging of the liver in patients with diffuse parenchymal liver disease. Eur J Radiol 2009; 72: 314-320.
18. Nikolaou K, Schoenberg SO, Brix G, Goldman JP, Attenberger U, Kuehn B, Dietrich O, Reiser MF,. Quantification of pulmonary blood flow and volume in healthy volunteers by dynamic contrast-enhanced magnetic resonance imaging using a parallel imaging technique. Invest Radiol 2004; 39: 537-545. (Pubitemid 39096771)
19. Rofsky NM, Lee VS, Laub G, Pollack MA, Krinsky GA, Thomasson D, Ambrosino MM, Weinreb JC,. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999; 212: 876-884. (Pubitemid 29410996)
20. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann H-J,. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: 715-724. (Pubitemid 41546838)
21. Schuhmann-Giampieri G, Schmitt-Willich H, Press W-R, Negishi C, Weinmann H-J, Speck U,. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183: 59-64.
22. Soher BJ, Dale BM, Merkle EM,. A review of MR physics: 3T versus 1.5T. Magn Reson Imaging Clin N Am 2007; 15: 277-290. (Pubitemid 47429999)
23. Goncalves Neto JA, Altum E, Elazzazi M, Vaidean GD, Chaney M, Semelka RC,. Enhancement of abdominal organs on hepatic arterial phase: quantitative comparison between 1.5- and 3.0-T magnetic resonance imaging. Magn Reson Imaging 2010; 28: 47-55.
24. Brasch RC, Weinmann H-J, Wesbey GE,. Contrast-enhanced NMR imaging: Animal studies using gadolinium-DTPA complex. AJR Am J Roentgenol 1984; 142: 625-630. (Pubitemid 14199124)
25. 2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T. Eur Radiol 1997; 7: 264-274. (Pubitemid 127538594)
26. Lu H, Clingman C, Golay X, van Zijl PC,. Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med 2004; 52: 679-682. (Pubitemid 39108984)